Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Business & Regulation Standards & Regulation

Crisis-Ready: Building a Resilient Supply

Drawing on lessons learned from the COVID-19 pandemic, the European Commission has developed a plan to secure affordable medicines for patients across the region (1). Pharmaceutical Strategy for Europe aims to create a regulatory approach that offers guidance on the management of future crises and supply chain resilience. The strategy also outlines the Commission’s goals for creating a competitive industry with a “strong voice” on issues affecting the global pharmaceutical community.

“Moving forward, there are too many public health, social and economic interests at stake here to get this wrong,” said Medicines for Europe President Christoph Stoller in a statement (2). “We strongly believe that all concerned stakeholders need to work together […] if we are to effectively deliver on the strategy’s ambition and ensure that patients receive the medicines they need when they need them, while keeping a strong, resilient and sustainable manufacturing base in Europe.”

For more information about the plan, visit

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. European Commission (2020). Available at
  2. Medicines for Europe (2020). Available at
About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Related White Papers
Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine